CIN2/CIN3, early cervical Ca prevented by HPV vaccine: two human papillomavirus vaccines are in phase III clinical trials. Interim results on Gardasil ... An article from: Skin & Allergy News

This digital document is an article from Skin & Allergy News, published by Thomson Gale on November 1, 2005. The length of the article is 986 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: CIN2/CIN3, early cervical Ca prevented by HPV vaccine: two human papillomavirus vaccines are in phase III clinical trials. Interim results on Gardasil show it to be effective.(Cancer prevention)(Drug overview)
Author: Sherry Boschert
Publication:Skin & Allergy News (Magazine/Journal)
Date: November 1, 2005
Publisher: Thomson Gale
Volume: 36 Issue: 11 Page: 5(1)

Article Type: Drug overview

Distributed by Thomson Gale